ACITRETIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 801 adverse event reports in the FDA FAERS database where ACITRETIN was used for Psoriasis.
Most Reported Side Effects for ACITRETIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 802 | 29.5% | 27 | 102 |
| Psoriasis | 474 | 17.4% | 9 | 86 |
| Off label use | 284 | 10.4% | 29 | 41 |
| Nausea | 192 | 7.1% | 2 | 23 |
| Pruritus | 184 | 6.8% | 6 | 18 |
| Arthralgia | 179 | 6.6% | 0 | 13 |
| Condition aggravated | 171 | 6.3% | 3 | 45 |
| Diarrhoea | 160 | 5.9% | 1 | 11 |
| Psoriatic arthropathy | 150 | 5.5% | 0 | 6 |
| Treatment failure | 147 | 5.4% | 4 | 14 |
| Hypertension | 133 | 4.9% | 0 | 23 |
| Myalgia | 122 | 4.5% | 0 | 3 |
| Therapeutic product effect incomplete | 121 | 4.5% | 0 | 8 |
| Skin exfoliation | 117 | 4.3% | 1 | 21 |
| Fatigue | 112 | 4.1% | 2 | 7 |
Other Indications for ACITRETIN
Product used for unknown indication (787)
Pustular psoriasis (129)
Pityriasis rubra pilaris (103)
Erythrodermic psoriasis (64)
Keratosis follicular (62)
Lichen planus (54)
Hidradenitis (48)
Ichthyosis (32)
Skin cancer (29)
Skin disorder (29)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)